Medprin Regenerative Medical Technologies Co. Ltd.
Medprin Regenerative Medical Technologies Co., Ltd. engages in the research, development, manufacture, and sale of implantable medical devices. The company offers artificial dura matermembrane patches, craniomaxillofacial repair and fixation systems, and absorbable regenerative oxidation for neurosurgery meningeal repair, skull repair fixation and rapid hemostasis, etc. It also offers ReDura, a S… Read more
Medprin Regenerative Medical Technologies Co. Ltd. (301033) - Total Assets
Latest total assets as of June 2025: CN¥805.10 Million CNY
Based on the latest financial reports, Medprin Regenerative Medical Technologies Co. Ltd. (301033) holds total assets worth CN¥805.10 Million CNY as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Medprin Regenerative Medical Technologies Co. Ltd. - Total Assets Trend (2019–2024)
This chart illustrates how Medprin Regenerative Medical Technologies Co. Ltd.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Medprin Regenerative Medical Technologies Co. Ltd. - Asset Composition Analysis
Current Asset Composition (December 2024)
Medprin Regenerative Medical Technologies Co. Ltd.'s total assets of CN¥805.10 Million consist of 39.1% current assets and 60.9% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 7.2% |
| Accounts Receivable | CN¥24.16 Million | 3.0% |
| Inventory | CN¥34.28 Million | 4.3% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥95.05 Million | 11.9% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2019–2024)
This chart illustrates how Medprin Regenerative Medical Technologies Co. Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Medprin Regenerative Medical Technologies Co. Ltd.'s current assets represent 39.1% of total assets in 2024, a decrease from 65.5% in 2019.
- Cash Position: Cash and equivalents constituted 7.2% of total assets in 2024, down from 8.4% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, a decrease from 15.0% in 2019.
- Asset Diversification: The largest asset category is intangible assets at 11.9% of total assets.
Medprin Regenerative Medical Technologies Co. Ltd. Competitors by Total Assets
Key competitors of Medprin Regenerative Medical Technologies Co. Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Medprin Regenerative Medical Technologies Co. Ltd. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Medprin Regenerative Medical Technologies Co. Ltd. generates 0.35x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Medprin Regenerative Medical Technologies Co. Ltd. generates $9.87 in net profit.
Medprin Regenerative Medical Technologies Co. Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 7.23 | 6.54 | 13.92 |
| Quick Ratio | 6.28 | 5.57 | 13.14 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥249.55 Million | CN¥ 192.77 Million | CN¥ 347.78 Million |
Medprin Regenerative Medical Technologies Co. Ltd. - Advanced Valuation Insights
This section examines the relationship between Medprin Regenerative Medical Technologies Co. Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.07 |
| Latest Market Cap to Assets Ratio | 0.37 |
| Asset Growth Rate (YoY) | 1.6% |
| Total Assets | CN¥799.23 Million |
| Market Capitalization | $296.25 Million USD |
Valuation Analysis
Below Book Valuation: The market values Medprin Regenerative Medical Technologies Co. Ltd.'s assets below their book value (0.37 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Medprin Regenerative Medical Technologies Co. Ltd.'s assets grew by 1.6% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Medprin Regenerative Medical Technologies Co. Ltd. (2019–2024)
The table below shows the annual total assets of Medprin Regenerative Medical Technologies Co. Ltd. from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥799.23 Million | +1.56% |
| 2023-12-31 | CN¥786.97 Million | +5.64% |
| 2022-12-31 | CN¥744.92 Million | -0.25% |
| 2021-12-31 | CN¥746.78 Million | +64.01% |
| 2020-12-31 | CN¥455.34 Million | +33.90% |
| 2019-12-31 | CN¥340.05 Million | -- |